Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,858 | 44,426 | 47,358 | 20,023 | 12,015 |
| Marketable Securities | N/A | 28,939 | 46,242 | 22,924 | 12,898 |
| TOTAL | $83,059 | $75,169 | $94,769 | $43,966 | $25,131 |
| Non-Current Assets | |||||
| PPE Net | 60 | 148 | 235 | 43 | 56 |
| Other Non-Current Assets | 233 | 201 | 87 | 166 | 0 |
| TOTAL | $293 | $350 | $322 | $209 | $56 |
| Total Assets | $83,353 | $75,518 | $95,091 | $44,175 | $25,188 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,660 | N/A | N/A | 116 | 78 |
| Accounts payable and accrued liabilities | 382 | 808 | 3,052 | 1,001 | 275 |
| Accrued Expenses | 8,135 | 11,873 | 5,422 | 2,237 | 1,946 |
| TOTAL | $12,410 | $12,908 | $8,473 | $3,354 | $2,299 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,435 | 14,528 | N/A | 1,220 | 1,239 |
| TOTAL | $11,435 | $14,528 | $N/A | $1,220 | $1,239 |
| Total Liabilities | $23,844 | $27,436 | $8,473 | $4,574 | $3,538 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,247 | 29,662 | 27,395 | 19,665 | 15,132 |
| Common Shares | 39 | 29 | 26 | 19 | 13 |
| Retained earnings | -236,916 | -199,362 | -138,535 | -99,642 | -77,301 |
| Other shareholders' equity | 0 | 6 | -9 | -18 | 0 |
| TOTAL | $59,509 | $48,082 | $86,618 | $39,601 | $21,650 |
| Total Liabilities And Equity | $83,353 | $75,518 | $95,091 | $44,175 | $25,188 |